MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
44.74
-1.06
-2.31%
After Hours: 44.47 -0.27 -0.60% 19:59 05/15 EDT
OPEN
45.40
PREV CLOSE
45.80
HIGH
45.50
LOW
44.25
VOLUME
16.38M
TURNOVER
--
52 WEEK HIGH
77.81
52 WEEK LOW
34.64
MARKET CAP
198.49B
P/E (TTM)
10.56
1D
5D
1M
3M
1Y
5Y
1D
FDA leadership fallout continues as acting CDER Director Hoeg expected to depart
Seeking Alpha · 1d ago
Novo Nordisk’s Cagrilintide Trial Signals Next Wave in Obesity Treatment
TipRanks · 1d ago
Novo Nordisk Expands Obesity Pipeline With AMAZE 6 Knee Osteoarthritis Trial
TipRanks · 1d ago
Mixed options sentiment in Novo Nordisk with shares down 2.61%
TipRanks · 1d ago
Buy, Sell, or Hold Novo Nordisk at $46?
The Motley Fool · 1d ago
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign?
The Motley Fool · 1d ago
Novo Nordisk: The First Fruits Of Labor
Seeking Alpha · 1d ago
Novo Nordisk (NYSE:NVO) Valuation Check After Mixed Year To Date And 1 Year Share Returns
Simply Wall St · 1d ago
More
About NVO
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.